In line with the mission to provide the most comprehensive and advanced cancer care in India, Apollo Proton Cancer Centre (APCC) has once again set a new standard with the introduction of the latest suite of cutting-edge cancer-fighting technology called Tomotherapy. As the first centre in South Asia and the Middle East to offer proton therapy, APCC is renowned for its commitment to providing the finest in proton and photon therapies, and the addition of Tomotherapy is a step towards offering advanced cancer care.
Ms. Kanimozhi Karunanidhi, Hon’ble Member of Parliament-Lok Sabha, Govt. of India, inaugurated Tamil Nadu’s first RadiXactX9 Tomotherapy and India’s first High Precession TMI/TMLI programme in the presence of Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, Mr Karan Puri, Chief Executive Officer, APCC, Dr Rakesh Jalali, Medical Director & HOD- Radiation Oncology, APCC, Dr Sapna Nangia, Senior Consultant – Radiation Oncology and Dr Srinivas Chilukuri, Senior Consultant Radiation Oncology, APCC, Mr. Manish Jaiswal, Regional Vice President, Accuray Medical Equipment India Pvt. Ltd.
APCC is now the first in Tamil Nadu to offer RadiXactX9 Tomotherapy and India’s first High Precession TMI/TMLI programme, thanks to its Helical Tomotherapy technology, which provides greater precision and control over radiation therapy delivery while minimising damage to healthy tissues. The daily imaging capability makes it possible for clinicians to identify and correct any variations in patient positioning, changes in the tumour, or other factors, such as weight gain or loss. As the Tomotherapy System’s precision reduces radiation exposure to surrounding healthy tissues, patients experience fewer side effects than those receiving conventional forms of radiation therapy.
Ms. Kanimozhi Karunanidhi, Hon’ble Member of Parliament-Lok Sabha, praised APCC’s role in offering advanced cancer care, saying, “Tamil Nadu has always been at the forefront of medical infrastructure and healthcare delivery in India, and I am proud to say that the launch of Tomotherapy at the Apollo Proton Cancer Centre is yet another example of this. With this new technology, the APCC is not only setting new standards for cancer care in Tamil Nadu but also in South Asia and the Middle East. I commend the APCC for its commitment to delivering the finest in proton and photon therapies, and for investing in the latest and most advanced technologies to enhance cancer care for patients.”
Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprises Ltd, added, ” The launch of Tomotherapy at the Apollo Proton Cancer Centre marks a momentous occasion that will redefine cancer treatment in South Asia. With the increasing prevalence of cancer in India, projected to grow seven-fold by 2025 due to various factors such as air pollution, smoking, and sedentary lifestyles, the introduction of this technology comes at a critical time. Apollo has been a pioneer in healthcare, setting high standards for patient care and excellence, and this commitment is reflected in the Apollo Proton Cancer Centre’s efforts to provide the finest in proton and photon therapies. The launch of Tomotherapy is yet another testament to this commitment, which is sure to positively impact the lives of countless patients not only in Tamil Nadu but also throughout South Asia and beyond.”
Dr. Rakesh Jalali, Medical Director & HOD- Radiation Oncology, APCC, emphasized the importance of the new technology, saying, “Tomotherapy represents a significant advancement in radiation therapy technology, and we are proud to be at the forefront of this development at the Apollo Proton Cancer Centre. With Tomotherapy, we are able to offer our patients a high-level of precision and accuracy in radiation therapy that was once thought impossible. At APCC, we are committed to providing the finest in proton and photon therapies, and Tomotherapy is a significant addition to our suite of advanced cancer-fighting technologies.”
Tomotherapy at the APCC underscores the centre’s commitment to offering the most advanced and effective cancer-fighting technologies in South Asia. With a dedicated comprehensive site-specific cancer care centre with all the latest diagnostic facilities including South Asia’s first digital PET-CT and digital pathology, APCC has an experienced multi-disciplinary team of highly skilled clinicians focused on delivering the best possible outcomes for their patients with utmost care.
